Skip to main content
. Author manuscript; available in PMC: 2024 May 3.
Published in final edited form as: Ann Surg. 2019 Jul;270(1):12–20. doi: 10.1097/SLA.0000000000003201

Table 2:

Clinicopathologic characteristics of patients with benign or low-grade malignant tumors.

Patient Age Procedure Final Pathology TBR
6 75 DP Mixed-type IPMN with low grade dysplasia 7.82
8 71 PD Well differentiated pancreatic neuroendocrine tumor 1.06
9 44 DP Microcystic serous cystadenoma 5.31
12 83 DP Main duct IPMN with high grade dysplasia 2.13
14 22 DP Neurofibroma 1.00
15 61 PD Mixed-type IPMN with high grade dysplasia 1.43
18 72 PD Serous cystadenoma 0.98
20 47 DP Well differentiated pancreatic neuroendocrine tumor 0.99

Abbreviations: TBR tumor-to-background ratio, DP distal pancreatectomy, IPMN intraductal papillary mucinous neoplasm, PD pancreaticoduodenectomy